2022
DOI: 10.1016/j.vaccine.2022.09.054
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 19 publications
0
8
0
Order By: Relevance
“…Nevertheless, in the context of the PERTINENT study, we presented in 2022, in an analysis restricted to the five sites recommending vaccination in pregnancy, our results on the effect of both vaccination in pregnancy and primary vaccination in infants aged 2–11 months. We found a similarly good VE of at least one dose of PV, irrespective of maternal vaccination (estimated at around 74–95 % when mothers were vaccinated in pregnancy and 68–94 % with unvaccinated mothers) [21] . Sample size limitations prevented us to conclude on a potential interaction between the two vaccinations.…”
Section: Discussionmentioning
confidence: 51%
See 1 more Smart Citation
“…Nevertheless, in the context of the PERTINENT study, we presented in 2022, in an analysis restricted to the five sites recommending vaccination in pregnancy, our results on the effect of both vaccination in pregnancy and primary vaccination in infants aged 2–11 months. We found a similarly good VE of at least one dose of PV, irrespective of maternal vaccination (estimated at around 74–95 % when mothers were vaccinated in pregnancy and 68–94 % with unvaccinated mothers) [21] . Sample size limitations prevented us to conclude on a potential interaction between the two vaccinations.…”
Section: Discussionmentioning
confidence: 51%
“…To further enhance protection for this vulnerable population, the consideration of pertussis vaccination during pregnancy is essential to protect younger infants aged <2 months who are not yet eligible to receive the first dose of aP vaccine. This vaccination strategy was also observed as protective in the context of the PERTINENT study [21] . Addressing this immunisation gap is of utmost importance for this age group with the highest risk of severe complications and mortality.…”
Section: Discussionmentioning
confidence: 71%
“…One prematurely born infant died, underlining the severity of pertussis in the youngest age group. The multi-country European Centre for Disease Prevention and Control (ECDC)-funded PERTINENT (Pertussis in Infants Network) study found that vaccination of women during pregnancy reduced hospitalisation in infants < 2 months of age by 75–88% [ 9 ]. In addition to a lower incidence among infants in Denmark during the 2023 epidemic, both the number and the proportion of infants admitted to the hospital was lower in 2023 compared with 2019 and 2016.…”
Section: Discussionmentioning
confidence: 99%
“…It is thus necessary to promote additional immunisation strategies besides one booster dose in adolescents, including vaccination during pregnancy ( 1 , 15 , 16 ). In our study we noticed that infants with pertussis were under-vaccinated compared to the vaccination schedule.…”
Section: Discussionmentioning
confidence: 99%